GW Pharma (GWPH) Reports Q1 Loss Per ADS of $2.43

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($2.43), may not compare to the analyst estimate of ($2.13).

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c